Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A11219 | Pages: NA | Charts: NA | Tables: NA |
A nephrostomy is a thin, plastic tube (catheter) that is inserted through the skin on from the back and into your kidney. Certain patients may have a catheter into each kidney. This drains urine from one or even both of the kidneys into a collecting bag outside the individual's body. Furthermore, the bag has a tap so that one can easily empty it. It is also possible that the individual passes the urine in the normal way even if the nephrostomy tube is kept inserted in one, or both the kidneys. This placement of the stent in the ureter is carried out with the assistance of the image-guidance by the physicians. One of the types is Percutaneous nephrostomy, which is performed in the cases of failure of placement of the ureteral stent, to help restore the flow of urine. This allows a rise in demand for nephrostomy devices, which are extensively used for the treatment of hydronephrosis. Ureters may become obstructed due to certain conditions such as blood clots, tumors, kidney stones, and infection, causing the blockage of urine flow. Therefore, ureteral stents and nephrostomy devices are in general used to restore urine flow and ensure that it passes through the blocked ureters, which allows the kidney to function normally.
COVID-19 scenario analysis:
The infected population requires medical supplies such as atomizer, life-support machine, oxygen generator, and monitor for sustaining. The growth in the number of individuals having COVID-19 is also boosting the need for the respiratory support devices and hence is anticipated to boost the medical supplies market in the coming years. These are majorly used medical devices in primary clinical treatment. Furthermore, COVID-19 has led to a rise demand for medical supplies that can be used to prevent the spread of infection such as personal protective equipment including masks, gloves, and protective eyeglasses. Both healthcare professionals and civil population need these personal protective equipment in order to ensure that the precautionary measures are taken care of. Manufacturers of these medical devices have a chance to gain maximum revenue in the near future.
The major factor affecting the industry includes increase in prevalence of urological diseases such as bladder obstruction, kidney stones, urinary retention, bladder cancer, prostate cancer and hydronephrosis, which would boost the industry in the forecast period. The surge in the number of procedures for percutaneous nephrostomy, is also expected to propel the Nephrostomy Device market in the next few years. The surge in demand for minimally invasive procedures and growth in awareness for availing better quality of life would help the market flourish in the coming years. However, the stringent regulations may impede the growth of the Nephrostomy Device market in the commenced period.
In February 2017, Cook Medical has rounded out the Universal line with the introduction of two new sets for percutaneous urinary drainage. Each set includes a catheter and accessories for specific procedures. These sets streamline Cook’s offering of percutaneous drainage products.
In September 2018, Boston Scientific Corporation announced the global launch of the LithoVue Empower Retrieval Deployment Device, designed to be utilized with the LithoVue Single-Use Digital Flexible Ureteroscope and compatible nitinol retrieval basket to enable urologists to operate an ureteroscope and basket simultaneously when retrieving kidney stones via flexible ureteroscopy (URS). The LithoVue Empower Device is one of the several new devices Boston Scientific is planning that addresses unmet needs and inefficiencies during stone procedures through innovation.
According to the estimates given by the National Kidney Foundation, the lifetime risk of kidney stones is approximately 19% in men and 9% in women. Furthermore, in men, the first episode is expected to occur after age 30, but it can occur earlier. Other diseases such as diabetes, high blood pressure, and obesity may increase the risk for kidney stones.
According to the estimations of Center of disease Control and Prevention, the precise number of people who are affected by DVT/PE (also called venous thromboembolism) are expected to be 900,000 people and about (1 to 2 per 1,000) each year in the U.S. Furthermore, the estimates suggest that 60,000-100,000 Americans die of DVT/PE. Surge in number of people experiencing blood clots may lead to the blockage of ureters, hence the need for the nephrostomy devices for assistance in the management would propel the market growth during the forecast period
Key benefits of the report:
Questions answered in the nephrostomy device market research report:
Key Market Segments
Key Market Players
Other Players